Robotic Surgery Giant Crashes After Guiding To Its Slowest Growth In Years

Licensing

Intuitive Surgical (ISRG) stock tumbled Friday after the robotics giant handily beat Wall Street's procedure growth expectations in the second quarter, but didn't raise its outlook. Instead, Intuitive said it expects the number of full-year procedures using its all-important da Vinci robotic surgery system to grow close to the midpoint of its previous guidance for 13.5% to 15.5%. That followed…